In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Royalty Flush: Why Monetizing Tomorrow's Revenue Stream Today Could Catch on in a Big Way

Executive Summary

Biotechs remain voracious consumers of capital, but tapping the equity markets is often prohibitively dilutive. Royalty financing can provide lower-cost-of-capital funding while putting a price on assets the market often ignores. This cash can also allow biotechs to hold onto R&D projects longer, eventually pushing up the price of licensing deals. But although royalty financiers are eager, they are limited in the amount of risk they are willing to take; new players in the business though may nevertheless increase competition and drive prices up.
Advertisement

Related Content

Vertex: Preparing to Go Commercial
Call the Plumber: PIPE Logic is Leaky
Symphony's Project Financing Model Adapts
Biopharma in 2008: What a Difference an Economic Crisis Makes
Credit Woes Hit Pharma
Pharma's Strategic Divide: Focus or Diversify
Alzheimer's Development Financing: Risky Therapies Call for Innovative Deals
Pharmaceutical Strategic Outlook: The Trouble with Alliances
No Dilution Necessary: The Promise of Project Financing
How Much for That Money in the Window?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003136

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel